BetterScholar BetterScholar
9
Role
Title
Level Year L/R
🐜 Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.
17 auth. L. Sullivan, S. J. Bowne, D. Birch, D. Hughbanks-Wheaton, J. Heckenlively, R. Lewis, Charles A. Garcia, R. S. Ruiz, S. Blanton, H. Northrup, ... Anisa I. Gire, R. Seaman, Hatice Duzkale, Catherine J. Spellicy, Jingya Zhu, S. Shankar, S. Daiger
8 2006
8
🐜
🐜 Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis.
12 auth. S. J. Bowne, L. Sullivan, Sir Mortimer, L. Hedstrom, Jingya Zhu, Catherine J. Spellicy, ... Anisa I. Gire, D. Hughbanks-Wheaton, D. Birch, R. Lewis, J. Heckenlively, S. Daiger
7 2006
7
🐜
🐬 Patient ocular conditions and clinical outcomes using a PROSE scleral device.
Ryan Dimit, Anisa I. Gire, S. Pflugfelder, J. Bergmanson
6 2013
6
🐬
🐬 The relationship between Graves’ ophthalmopathy and dry eye syndrome
J. Selter, Anisa I. Gire, S. Sikder
6 2014
6
🐬
🐬 The impact of the Boston ocular surface prosthesis on wavefront higher-order aberrations.
K. Gumus, Anisa I. Gire, S. Pflugfelder
5 2011
5
🐬
🦁 The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa.
7 auth. Anisa I. Gire, L. Sullivan, S. J. Bowne, D. Birch, D. Hughbanks-Wheaton, J. Heckenlively, ... S. Daiger
5 2007
5
🦁
🦁 PROSE treatment for lagophthalmos and exposure keratopathy.
Anisa I. Gire, Alan Kwok, Douglas P. Marx
5 2013
5
🦁
🐜 Mutations in the TOPORS gene cause 1% of autosomal dominant retinitis pigmentosa
7 auth. S. J. Bowne, L. Sullivan, Anisa I. Gire, D. Birch, D. Hughbanks-Wheaton, J. Heckenlively, ... S. Daiger
5 2008
5
🐜
🐬 PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects.
Jeanie D Ling, Anisa I. Gire, S. Pflugfelder
5 2013
5
🐬